To further characterize the conformational changes in tau, we assessed the labeling efficiency of the clinical positron emission tomography (PET) ligand PBB3, which has been used to visualize tau burden in human tauopathy patient samples and Tg mouse models [58, 62]. Here, MAPT is linked to tauopathy.